Bacterial infections are very difficult to treat when bacteria spread into the bloodstream and begin to replicate within deep tissues, such as the spleen. Subsets of bacteria can survive antibiotic treatment, but it remains unclear if this survival is because of limited drug diffusion into tissues, or if there are changes within the bacteria, promoting survival of some bacterial cells. Here, we have developed a fluorescent reporter to detect doxycycline (Dox) diffusion into host tissues, and we show that Dox impacts the bacterial population within hours of administration and inhibits bacterial growth for 48 h. However, bacterial growth resumes when antibiotic concentrations decrease. Subsets of bacteria, stressed by the host response to infection, survive Dox treatment at a higher rate. These results provide critical information about the dynamics that occur within deep tissues following antibiotic administration and suggest that subsets of bacteria are predisposed to survive inhibitory concentrations of antibiotic before exposure.
KEYWORDS: antibiotic diffusion, doxycycline, fluorescent reporter, systemic infection, tetracycline derivatives, Yersinia
ABSTRACT
Severe systemic bacterial infections result in colonization of deep tissues, which can be very difficult to eliminate with antibiotics. It remains unclear if this is because antibiotics are not reaching inhibitory concentrations within tissues, if subsets of bacteria are less susceptible to antibiotics, or if both contribute to limited treatment efficacy. To detect exposure to doxycycline (Dox) present in deep tissues following treatment, we generated a fluorescent transcriptional reporter derived from the tet operon to specifically detect intracellular tetracycline exposure at the single bacterial cell level. Dox exposure was detected in the spleen 2 h after intraperitoneal injection, and by 4 h postinjection, this treatment resulted in a significant decrease in viable Yersinia pseudotuberculosis bacteria in the spleen. Nitric oxide-stressed bacteria preferentially survived treatment, suggesting that stress was sufficient to alter Dox susceptibility. Many bacteria (∼10%) survived a single dose of Dox, and the antibiotic accumulated at the periphery of microcolonies to growth inhibitory concentrations until 48 h posttreatment. After this time point, antibiotic concentrations decreased and bacterial growth resumed. Dox-treated mice eventually succumbed to the infection, albeit with significantly prolonged survival relative to that of untreated mice. These results indicate that Dox delivery by intraperitoneal injection results in rapid diffusion of inhibitory concentrations of antibiotic into the spleen, but stressed cells preferentially survive drug treatment, and bacterial growth resumes once drug concentrations decrease. This fluorescent reporter strategy for antibiotic detection could easily be modified to detect the concentration of additional antimicrobial compounds within host tissues following drug administration.
INTRODUCTION
Bacterial infections are exceedingly difficult to treat with antibiotics when bacteria spread systemically into deep tissues. It is thought that this difficulty arises because the antibiotic cannot accumulate to inhibitory concentrations within these tissue sites, so bacteria are exposed to subinhibitory concentrations of the drug. It has been difficult to determine the antibiotic concentration present within deep tissues, and many studies have relied on serum concentrations to determine whether tissue contain inhibitory levels (1, 2). Recently, mass spectrometry-based assays have shown differential diffusion of tuberculosis drugs across granulomas (3). Biofilm structures also limit antibiotic diffusion into the center of bacterial communities. Both granulomas and biofilms contain stressed, slow-growing bacterial subpopulations at the center of the bacterial community, and it is thought that inhibitory concentrations of antibiotic cannot reach these cells, so they remain following treatment (4–8). Mass spectrometry could be used to better understand antibiotic diffusion within tissues but requires specialized technology for tissue processing, data collection, and analysis. Bacterial fluorescent reporters offer a cost-effective alternative that can detect spatiotemporal changes in antibiotic concentration across individual bacterial cells following treatment.
Slow-growing bacterial cells are known to be less susceptible to antibiotics, but it remains unclear which pathways promote slowed bacterial growth within host tissues (9, 10). Nutrient limitation may reduce metabolic activity and subsequently reduce antibiotic susceptibility (4, 11, 12). Host immune cell subsets can promote the formation of slow-growing bacteria within host tissues (13, 14), but it remains unclear if antimicrobial compounds such as reactive oxygen species (ROS) or reactive nitrogen species (RNS) contribute to slowed growth (15, 16). Recently, it was shown that ROS exposure was sufficient to reduce the rifampin susceptibility of Staphylococcus aureus during spleen infection (17). However, it remains unclear if bacterial cells responding to ROS preferentially survived drug treatment. Expression of virulence factors, and specifically type III secretion system (T3SS) expression, has been linked to slowed growth and decreased antibiotic susceptibility in Salmonella species, but this link has not been made within host tissues (18, 19).
Yersinia pseudotuberculosis replicates within deep tissue sites to form clonal extracellular clusters of bacteria called microcolonies (or pyogranulomas) (20–22). Within the spleen, neutrophils are recruited to sites of bacterial replication and directly contact bacteria at the periphery of microcolonies. Peripheral bacteria respond to neutrophil contact by expressing high levels of the type III secretion system (T3SS), which promotes translocation of T3SS effector proteins into neutrophils and inhibits phagocytosis. A layer of monocytes is recruited immediately around the layer of neutrophils. Recruited monocytes develop characteristics of dendritic cells and macrophages (20–22) and express inducible nitric oxide synthase (iNOS), which produces antimicrobial nitric oxide (NO) that diffuses toward the microcolony. Bacteria at the periphery of the microcolony respond to NO by expressing the NO-detoxifying gene, hmp (22). hmp expression at the periphery prevents NO diffusion into the center of microcolonies, establishing an example of cooperative behavior in which the peripheral bacteria protect the interior bacteria from the antimicrobial action of NO (22, 23). It remains unclear if the protective expression of hmp by peripheral cells comes at a fitness cost, and if this stress response is sufficient to alter the antibiotic susceptibility of this subpopulation.
The genetic tools available for Y. pseudotuberculosis allow us to easily construct fluorescent reporters to detect changes in the host environment at the single-bacterium level (22–24). Here, we introduce a tetracycline-responsive fluorescent reporter based on the tet operon that enables detection of the diffusion of tetracycline derivatives, including doxycycline (Dox), within host tissues. Dox was chosen for these studies because it is a relevant bacteriostatic antibiotic for treatment of Yersinia infection (25–27), but similar reporters could also be generated for other classes of antibiotics. This tool allows us to determine if individual bacteria are differentially exposed to antibiotics during drug treatment within mouse tissues and to more closely approximate antibiotic concentrations within host tissues.
RESULTS
Characterizing the doxycycline-responsive reporter.
Bacterial infections of deep tissues are exceedingly difficult to treat, and it is thought that this is because the concentration of antibiotic does not reach inhibitory levels within deep tissue sites. Here, we establish a reporter system to detect Y. pseudotuberculosis antibiotic exposure within deep tissues, using an antibiotic prescribed to treat infection, doxycycline (Dox), to better understand what occurs within host tissues after antibiotic administration. To detect antibiotic diffusion and exposure, we constructed a tetracycline-responsive transcriptional reporter within a low-copy plasmid (pMMB67EH), and transformed the reporter into wild-type (WT) Y. pseudotuberculosis. The reporter contains a constitutively expressed tetR gene whose gene product, TetR, binds to DNA and represses expression of PtetA::mCherry in the absence of tetracycline derivatives. In the presence of tetracyclines, drug binding to TetR relieves repression, and transcription of mCherry occurs (see Fig. S1A in the supplemental material).
To determine if the PtetA reporter can be used to quantify the amount of Dox exposure within individual bacteria, we treated liquid cultures of the reporter strain with increasing doses of Dox. Bacterial growth (A600) and mCherry fluorescence were quantified in a microplate reader. Treatment with 1 μg/ml Dox resulted in growth inhibition consistent with published MIC levels for Yersinia and close to the maximum Dox concentration range that can be obtained within mouse and human serum (Fig. S1B) (2, 28–30). Reporter signal was detected with 0.01 μg/ml Dox and significantly increased with 0.1 μg/ml Dox (Fig. S1B and C). Exposure to 1 μg/ml resulted in decreased reporter expression, likely due to ribosomal inhibition by Dox. Reporter signal was first detected after 2 h of antibiotic exposure and significantly increased after 4 h of exposure (Fig. S1C).
Plate reader measurements give averaged, population-level readings; to detect heterogeneity across individual bacterial cells, reporter signal quantified at the single-cell level by fluorescence microscopy. Single-cell quantification also showed that 0.01 μg/ml Dox increased reporter signal, 0.1 μg/ml Dox significantly increased signal, and 1 μg/ml treatment decreased reporter signal within individual cells (Fig. S1D). Cells within each treatment group had distinct levels of fluorescent signal in response to Dox, suggesting that this reporter will be a useful tool for determining antibiotic exposure levels. Collectively, these results confirm the reporter responds to Dox and can be used to detect antibiotic exposure within individual bacterial cells.
Doxycycline differentially diffuses across microcolonies.
To determine if Dox can diffuse into microcolonies and impact bacterial growth, we infected C57BL/6 mice intravenously with green fluorescent-protein-positive (GFP+) PtetA::mCherry Y. pseudotuberculosis and injected mice intraperitoneally with 40 mg/kg Dox at 48 h postinoculation (h p.i.). The 48-h time point p.i. was chosen to allow microcolonies to initially replicate and form distinct bacterial subpopulations prior to antibiotic treatment (22); intraperitoneal administration of 40 mg/kg Dox should result in inhibitory levels of Dox in the serum (1 to 4 μg/ml) within hours of injection (31, 32). Spleens were harvested at 24 h posttreatment to quantify CFU, microcolony areas, and reporter expression (Fig. 1A). Dox treatment resulted in significantly fewer CFU relative to those in untreated mice; however, ∼105 CFU remained in the spleen 24 h after treatment (Fig. 1B). The area of microcolonies was also significantly lower following 24 h of Dox treatment compared to that in untreated mice, suggesting that antibiotic treatment either inhibited growth of microcolonies or promoted elimination of a subset of bacteria (Fig. 1C).
To determine if Dox diffused into microcolonies, the Dox-responsive reporter signal was compared to that of a constitutively expressed GFP. Reporter signal was significantly higher at the centroid of microcolonies compared to that at the periphery (outside dotted white line), suggesting that Dox diffused into the microcolony and that there was differential diffusion of Dox across microcolonies at 24 h posttreatment (Fig. 1D and E). Colocalization analysis was used to highlight differences in mCherry signal intensity across microcolonies and shows high mCherry reporter expression in the middle of microcolonies (fuchsia) and low mCherry signal within peripheral cells (teal) (Fig. 1F). Decreased reporter signal at the periphery may indicate that heightened levels of antibiotic accumulate at this location, limiting the translational activity of peripheral cells. However, it could also suggest antibiotic accumulation at the centroid of microcolonies and lower concentrations at the periphery.
Tetracycline derivatives accumulate at the periphery of microcolonies.
Our initial experiments in Fig. 1 utilized a reporter constructed with a stable mCherry fluorescent protein, which means reporter signal could accumulate over the course of the experiment. To confirm that reporter signal represents current responses to Dox, we generated a fluorescent reporter construct with a destabilized mCherry fluorescent protein. The destabilized mCherry within this construct has a ssrA tag (mCherry-ssrA), which targets mCherry for proteasomal degradation and quickens protein turnover (33, 34). mCherry-ssrA has a half-life of 35.5 min (Fig. 2A), which allows detection of recent responses to the antibiotic. Liquid cultures of the destabilized reporter strain were treated with increasing doses of Dox, and fluorescent reporter expression was quantified at 4 h posttreatment in a plate reader. Reporter expression patterns for the destabilized reporter were similar to those of the stable reporter at 4 h; destabilized fluorescent signal was maximal with 0.1 μg/ml Dox (Fig. 2B).
To determine if the Dox concentrations at the periphery of microcolonies are reaching levels that inhibit translation, we performed experiments with the inactive tetracycline derivative anhydrotetracycline (ATc). ATc can bind TetR and derepress the tet operon; however, ATc has an ∼35× lower binding affinity for E. coli ribosomes than that of Dox (35, 36). As it remained unclear if high concentrations of ATc impact Y. pseudotuberculosis growth, we treated liquid cultures of the reporter strain with increasing doses of ATc and detected growth and fluorescence with a microplate reader. Growth was significantly reduced with 1 μg/ml Dox but was not significantly impacted by 1 μg/ml ATc (Fig. 2C). Reporter signal was detected with 0.01 μg/ml ATc and was significantly increased with 0.1 μg/ml ATc. ATc at 1 μg/ml also resulted in high levels of reporter expression, in contrast to results with Dox, suggesting that ATc does not significantly inhibit ribosomal activity at this dose (Fig. 2D). Similar patterns were seen using flow cytometry to detect fluorescent reporter signals (see Fig. S2 in the supplemental material). The high level of reporter expression with 1 μg/ml ATc suggested that we could use ATc treatment to determine if peripheral bacteria are exposed to higher levels of antibiotic than the centroid, as increasing doses of ATc result in a heightened reporter signal.
We then used the destabilized reporter strain in combination with Dox or ATc treatment to determine the concentration of antibiotics within microcolonies, to determine when antibiotic exposure occurs after treatment, and to confirm that spatial differences in reporter signal are not due to accumulation of stable fluorescent protein. Mice were infected intravenously with the GFP+ PtetA::mCherry-ssrA strain and treated at 48 h p.i., and splenic tissue was harvested at 2, 4, and 24 h posttreatment (Fig. 3A). Reporter expression was significantly higher at the centroid of microcolonies after 24 h of Dox treatment, suggesting that differential reporter expression is not due to accumulation of stable fluorescent protein (Fig. 3B). Reporter signal was detected 2 h after Dox injection and was similar to that detected after exogenous addition in culture, indicating that bacteria are exposed to the antibiotic soon after intraperitoneal injection (Fig. 3B). During ATc treatment, reporter expression was significantly higher at the periphery of the microcolony compared to that at the centroid (Fig. 3C). Based on in vitro reporter expression (Fig. 2B and D), these results suggest that peripheral bacteria are exposed to inhibitory levels of ∼1 μg/ml tetracyclines, while the interior is exposed to lower subinhibitory concentrations, around 0.1 μg/ml.
Microcolonies significantly decrease in size after doxycycline treatment.
Dox was first detected within host tissues at 2 h posttreatment (Fig. 3B), but it remained unclear how antibiotic administration impacted bacterial growth and viability. To address this, the splenic tissue depicted in Fig. 3 was also harvested to quantify CFU and microcolony areas. CFU decreased 2 h after Dox treatment, and there was a significant reduction in CFU at 4 h of Dox treatment relative to that with ATc treatment (Fig. 4A). The difference in CFU was more pronounced at 24 h posttreatment, where Dox treatment resulted in significantly fewer CFU compared to those with ATc treatment or in untreated mice, and ATc treatment CFU were similar to those in untreated (72-h) mice (Fig. 4A). This suggested the difference in CFU was due to antibiotic activity. There was a significant reduction in microcolony areas between 4 and 24 h of Dox treatment, while microcolony areas increased slightly during ATc treatment, suggesting that Dox activity led to the decrease in microcolony areas (Fig. 4B). Consistent with this, at 24 h posttreatment, Dox treatment resulted in significantly smaller microcolony areas than ATc treatment or those in untreated (72-h) mice (Fig. 4B). ATc treatment also resulted in slightly smaller microcolonies than those in untreated tissue, suggesting there may have been some impact of ATc administration. These results suggest that many bacteria are eliminated following a single Dox treatment, while subsets of viable bacteria also remain within tissues at 24 h after treatment. We believe that smaller microcolonies present at 48 h p.i. are likely eliminated quickly by Dox, and the smaller microcolonies present at 24 h after treatment are remaining cells from larger microcolonies.
Hmp+ cells preferentially survive doxycycline treatment.
We hypothesized that peripheral bacterial cells stressed by the host immune response may have reduced metabolic activity, and may be predominant within the surviving bacterial population after Dox treatment. The 48-h treatment time point was specifically chosen throughout this study to allow the stressed bacterial subpopulation to develop prior to treatment, to then determine if stress impacts survival of this subpopulation. To determine whether Hmp+ cells preferentially survive Dox treatment, we infected C57BL/6 mice intravenously with GFP+ hmp::mCherry Y. pseudotuberculosis and treated mice with Dox or ATc at 48 h p.i., and splenic tissue was harvested at 2 and 4 h posttreatment to quantify CFU and quantify the proportion of Hmp+ bacteria by flow cytometry. Early time points posttreatment were used to specifically focus on early survival differences between Hmp-negative (Hmp−) and Hmp+ cells, and to limit the impact of cell division events that would complicate the analysis. CFU in the spleen were significantly lower with 2 and 4 h of Dox treatment compared to ATc treatment, suggesting that antibiotic activity contributed to decreased CFU (Fig. 5A). Hmp+ bacteria were detected by flow cytometry, by gating on the total GFP+ bacterial population in the spleen and quantifying the percentage of Hmp+ cells before and after treatment. Mice were infected with the GFP+ strain in parallel to define the threshold for mCherry+ cells. The percentage of Hmp+ cells significantly increased after 2 h of Dox treatment compared to that after 2 h of ATc treatment, suggesting that a higher proportion of the Hmp+, stressed cells were surviving Dox treatment than the Hmp−, unstressed cells, and that this was due to the activity of Dox (Fig. 5B). At 4 h posttreatment, the percentage of Hmp+ cells increased significantly with Dox treatment relative to that with ATc treatment and that in untreated mice, again suggesting that Hmp+ cells were preferentially surviving drug treatment (Fig. 5B and C). Dox treatment did not impact hmp transcript levels in vitro (Fig. 5D) or in the mouse spleen (Fig. 5E), indicating that bacteria express hmp prior to Dox exposure, and not as a response to treatment. Dox treatment caused a trend toward decreased hmp transcript levels both in vitro and in vivo, although this was not statistically significant. We also confirmed by flow cytometry that exposure to high levels of Dox (1 μg/ml) does not increase the mCherry signal of Y. pseudotuberculosis (Fig. S2), again suggesting that increased hmp reporter signal is due to preferential survival of Hmp+ cells. Collectively, these results indicate that the stressed Hmp+ bacteria at the periphery of microcolonies preferentially survive Dox treatment and that the Dox concentrations reaching the Hmp− interior of microcolonies is sufficient to eliminate a larger proportion of these cells.
Doxycycline treatment at 48 h p.i. significantly prolongs mouse survival.
Our results suggest that a single dose of Dox is sufficient to eliminate subsets of bacteria in the first 4 h after treatment, but it remained unclear if bacterial numbers continue to drop in the days following treatment and if this single dose is ultimately sufficient to clear infection. Survival curves were performed to determine if a single dose of treatment was sufficient to prolong mouse survival and clear infection. C57BL/6 mice were infected intravenously with the WT Y. pseudotuberculosis GFP+ strain, and the infection proceeded until mice reached defined morbidity endpoints. Spleens were plated to confirm morbidity was caused by a high level of CFU (107). Untreated mice had a median survival of 90 h (Fig. 6). One Dox dose at 48 h p.i. was sufficient to significantly prolong mouse survival relative to that of untreated mice; however, treated mice eventually succumbed to the infection, with a median survival of 156 h (Fig. 6). Injection of Dox at 72 h p.i. did not significantly prolong mouse survival (median survival, 96 h), suggesting that the treatment was not effective at this time point. These results suggest that a single dose of Dox is sufficient to significantly prolong mouse survival, but is not sufficient to promote clearance of the infection. The Hmp+ cells that initially survive treatment may persist for long periods of time and resume growth when stress and antibiotic concentrations decline.
Bacterial growth resumes when antibiotic concentrations drop.
The prolonged survival of mice in Fig. 6 suggests that bacterial growth may be restricted for several days after Dox administration, but that eventually bacterial growth resumes and mice succumb to the infection. To determine when bacterial growth resumes within the spleen, C57BL/6 mice were infected with the GFP+ PtetA::mCherry-ssrA strain, injected with Dox at 48 h p.i., and tissue was harvested at 48 and 72 h posttreatment to quantify CFU and microcolony areas (Fig. 7A). CFU count remained low at 48 h posttreatment, similar to that at 24 h posttreatment (Fig. 4A); however, there was a significant increase in CFU between 48 and 72 h posttreatment (Fig. 7B). There was also a significant increase in microcolony areas between 48 and 72 h posttreatment (Fig. 7C and E), suggesting that bacterial growth resumes between these time points posttreatment.
To determine if resumed bacterial growth correlates with a change in Dox concentration within the spleen, tissue was harvested at all indicated time points posttreatment to visualize Dox exposure by fluorescence microscopy (Fig. 7A). Microcolonies were detected based on constitutive GFP+ signal, and the total mCherry signal across the microcolony was divided by the total GFP to generate a relative exposure value (mCherry mean/GFP mean fluorescent signal) for each microcolony. Using this ratio to detect exposure, there was a significant increase in antibiotic exposure between 2 and 4 h posttreatment with Dox, which remained similar between 4 and 24 h posttreatment (Fig. 7D). Between 24 and 48 h posttreatment, there was a significant decrease in Dox exposure, and this exposure value remained low at 72 h posttreatment (Fig. 7D). This change in Dox exposure based on reporter expression was clearly apparent within microcolonies; many microcolonies retained some Dox reporter signal at 48 h posttreatment, but microcolonies were very large at 72 h posttreatment and had very little remaining reporter signal (Fig. 7E). These results show that Dox concentrations wane in the spleen at 48 h posttreatment, and bacterial growth resumes once the concentration of Dox in the spleen has dropped to subinhibitory levels, ultimately causing the mice to succumb to the infection. Presumably, the stress from host phagocytes has also dissipated at these late time points, permitting the resumption of bacterial growth.
DISCUSSION
To effectively eliminate infection, antibiotics must be able to penetrate into areas of bacterial replication at high concentrations. Here, we show that tetracyclines diffuse into deep tissue sites and promote the elimination of a majority of the bacterial population within hours of treatment. At 4 h posttreatment, we observed preferential survival of stressed Hmp+ cells, and subsequently, tetracyclines accumulate at the periphery of microcolonies between 4 and 48 h posttreatment. The accumulation occurs after we observe preferential survival, which suggests that Dox initially penetrates into microcolonies at doses inhibitory to Hmp− cells. It remains unclear if approximately 100 ng/ml Dox is inhibitory within the host environment, or if initial concentrations of Dox are higher than this approximation. The accumulation of antibiotic is sufficient to prevent bacterial growth, but once the concentration of Dox decreases, bacterial growth resumes, and mice succumb to the infection. These results suggest that penetration of high antibiotic concentrations is not sufficient to eliminate all bacterial cells from deep tissues, due to susceptibility differences of stressed bacterial cells. Unlike granulomas or biofilms, the stressed cells within microcolonies are located at the periphery of bacterial centers and are exposed to high, inhibitory levels of Dox, but this was still not sufficient to eliminate stressed cells.
The data presented here show that Hmp+ cells preferentially survive Dox treatment, suggesting that stress caused by NO may be sufficient to slow bacterial growth and reduce antibiotic susceptibility. However, the Hmp+ peripheral population is likely exposed to multiple different host-derived stresses, and it also contains a subpopulation of bacteria expressing very high levels of the T3SS (22). For this study, we used hmp reporter expression to mark the peripheral population, but we recognize that this is likely a very complex subpopulation, and additional studies will be needed to further characterize the transcriptomic and proteomic profile of this important subpopulation. Additional studies are also needed to truly show that Hmp+ cells represent a slow-growing subpopulation with decreased metabolic activity; however, the decreased antibiotic susceptibility of this population suggests this is likely the case (10–12).
During Dox treatment, many bacterial cells survive and are capable of resuming growth once antibiotic concentrations wane (Fig. 7). We hypothesize that smaller microcolonies are initially eliminated and that the surviving cells from larger microcolonies are primarily smaller, broken-down Hmp+ pieces. Our data suggest that surviving bacteria may be exposed to Dox concentrations ranging from 0.1 to 1 μg/ml for as long as 48 h, and it will be very interesting to determine how this prolonged exposure impacts the bacterial population. The genes expressed in response to Dox could be potential targets to more effectively eliminate the bacteria population with combination therapeutics. We expect that many of the genes expressed during this long term Dox exposure are protective responses that, if inhibited, would result in a loss of bacterial viability.
Doxycycline treatment has direct effects on the bacterial population, but the release of bacterial products at the site of infection will also impact the host response. Our experiments to detect preferential survival of the Hmp+ population were focused on early time points posttreatment, in part because we were interested in early perturbation by Dox, but also because interactions between bacteria and host cells are likely different at later hours posttreatment, as the host immune response becomes activated by release of bacterial ligands. As additional, activated immune cells subsets are recruited to the spleen, we expect the bacterial population to respond to their presence. It would be very interesting to further characterize the bacterial and host response at later time points after Dox treatment, which may provide important clues as to why the host response was not sufficient to completely eliminate the bacterial population.
Antibiotic susceptibility is typically assessed with in vitro experiments, and very few studies have focused on the impact of antibiotics in the host environment, where bacteria may respond very differently and may have very different susceptibility patterns. It is critical that we develop tools, such as the fluorescent reporter developed here, to study antibiotic activity, diffusion, and efficacy within mammalian tissues.
MATERIALS AND METHODS
Bacterial strains and growth conditions.
The WT Y. pseudotuberculosis strain IP2666 was used throughout (22, 37). For all mouse infection experiments, bacteria were grown overnight (16 h) to the postexponential phase in 2×YT broth (LB with 2× yeast extract and tryptone) at 26°C with rotation. For antibiotic exposure experiments, bacteria were grown in LB overnight (16 h) at 26°C with rotation, subcultured 1:100, and grown at 37°C with rotation in the absence or presence of the indicated concentrations of doxycycline (Dox) or anhydrotetracycline (ATc), until the indicated time points.
Murine model of systemic infection.
Six- to 8-week old female C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME). All animal studies were approved by the Institutional Animal Care and Use Committee of Johns Hopkins University. Mice were injected intravenously into the tail vein with 103 bacteria for all experiments. At the indicated time points postinoculation (p.i.), spleens were removed and processed. Intact tissue was stabilized for RNA isolation or fixed for fluorescence microscopy. Tissue was homogenized to quantify CFU and process for flow cytometry. For survival curves, the following morbidity endpoints were used: weight loss of 15% or greater (measured initially and every 24 h p.i.), lethargy, hunched stature, or reduced activity; any of these endpoints qualified mice for euthanasia. Spleens were plated to confirm morbidity was associated with high bacterial CFU counts.
Generation of reporter strains.
Two of the Y. pseudotuberculosis reporter strains in this study were previously described, WT GFP+ and WT GFP+ hmp::mCherry (22). GFP+ strains were constructed by transformation with the constitutive GFP plasmid, which expresses GFP from the unrepressed Ptet of pACYC184 (22, 24). The destabilized version of mCherry was constructed by fusing an 11-amino-acid ssrA tag, with AAV terminal amino acids, between the last coding amino acid of mCherry and the stop codon (33, 34). This was inserted downstream of the Ptac isopropyl-β-d-thiogalactopyranoside (IPTG)-inducible promoter in pMMB207Δ267 (38) to quantify mCherry half-life following IPTG induction. A stable WT mCherry construct was generated in parallel as a control. The PtetA::mCherry reporter was constructed by amplifying tetR through the PtetA promoter sequence from Tn10, fusing this to mCherry by overlap extension PCR to replace tetABC with mCherry, and cloning this into the low-copy pMMB67EH plasmid. PtetA::mCherry-ssrA was constructed the same way, by amplifying the ssrA-tagged, destabilized mCherry.
Fluorescence detection, plate reader.
Bacteria were washed in phosphate-buffered saline (PBS), resuspended in an equivalent volume of PBS, then added to black-walled, clear-bottomed 96-well plates. Optical density (A600) was used to approximate cell number; mCherry fluorescence was detected with 560-nm excitation and 610-nm emission, using a Synergy H1 microplate reader (BioTek).
Determining fluorescent protein half-life.
Overnight cultures (16 h) were grown in LB with 1 mM IPTG. Bacteria were washed 3× in PBS to remove IPTG and resuspended in PBS, and kanamycin (50 μg/ml) was added to inhibit additional protein translation. Bacteria were added to black-walled, clear-bottomed 96-well plates, and were incubated in a Tecan Infinite M200 microplate reader until the indicated time points. Fluorescence reads (580-nm excitation and 620-nm emission) were taken every 5 min. Detection (560-nm excitation/610-nm emission) with a Synergy H1 microplate reader (BioTek) gave equivalent results. Fluorescent protein half-life was calculated from six biological replicates using a one-phase exponential decay equation in Prism software.
Fluorescence microscopy: host tissues.
Spleens were harvested and immediately fixed in 4% paraformaldehyde (PFA) in PBS for 3 h. Tissues were frozen-embedded in SubXero freezing medium (Mercedes Medical) and cut by cryostat microtome into 10-μm sections. To visualize reporters, sections were thawed in PBS, stained with Hoechst stain at a 1:10,000 dilution, and washed in PBS, and coverslips were mounted using ProLong Gold (Life Technologies). Tissue was imaged as described above, with an Apotome.2 system (Zeiss) for optical sectioning.
Quantitative reverse transcription-PCR to detect bacterial transcripts in broth-grown cultures.
Bacterial cells were grown in the presence or absence of 0.1 μg/ml Dox for the indicated time points, pelleted, and resuspended in buffer RLT (Qiagen) plus β-mercaptoethanol, and RNA was isolated using the RNeasy kit (Qiagen). DNA contamination was eliminated using a DNA-free kit (Ambion). RNA was reverse transcribed using Moloney murine leukemia virus (MMLV) reverse transcriptase (Invitrogen) in the presence of the RNase inhibitor RNaseOUT (Invitrogen). Approximately 30 ng cDNA was used as a template in reactions with 0.5 μM forward and reverse primers (22) and SYBR green (Applied Biosystems). Control samples were prepared that lacked MMLV, to confirm that DNA was eliminated from samples. Reactions were carried out using the StepOnePlus real-time PCR system, and relative comparisons were obtained using the threshold cycle (ΔΔCT or 2−ΔCT) method (Applied Biosystems). Kits were used according to the manufacturers’ protocols.
Quantitative reverse transcription-PCR to detect bacterial transcripts from mouse tissues.
Spleens were harvested and immediately submerged in RNALater solution (Qiagen). Tissue was homogenized in buffer RLT plus β-mercaptoethanol, and RNA was isolated using the RNeasy kit (Qiagen). Bacterial RNA was enriched following depletion of host mRNA and rRNA from total RNA samples, using the MicrobEnrich kit (Ambion). Kits were used according to manufacturers’ protocols; DNA digestion, reverse transcription, and quantitative reverse transcription-PCR (qRT-PCR) were performed as described above.
Flow cytometry.
Homogenized tissue was treated with collagenase D and DNase I in PBS plus 0.2 mM EDTA to dissociate host cells from bacteria. Host cells were lysed with eukaryotic lysis buffer (5 mM EDTA, 0.1% NP-40, 0.15 M NaCl, and 1 M HEPES), debris were settled out of solution, and supernatant was collected, pelleted, and fixed in 4% PFA overnight at 4°C. Bacteria were detected using GFP signal and forward scatter (FSC; size), and 1,000 bacterial events were collected per tissue, using a BD FACSCalibur. For analysis, bacterial cells were gated based on GFP signal, and GFP+ bacterial controls lacking mCherry constructs (prepared and collected in parallel) were used to identify mCherry+ cells.
Image analysis.
Volocity image analysis software was used to quantify microcolony areas and fluorescence as previously described (22). Zen 2 colocalization software was used to generate an intensity dot plot for pixels within an image (Fig. 2F) with a corresponding pseudocolored image; each quadrant of the dot plot corresponds with a highlighted pseudocolor. Bacterial cells defined the GFP+ threshold; within this threshold, the pixels with the highest mCherry signal intensity (66%) were considered mCherryhigh, and pixels with the lowest (34%) mCherry signal intensity were considered mCherrylow. ImageJ was used to quantify the signal intensity of each channel at the centroid and periphery of each microcolony to generate relative signal intensities of fluorescent reporters, as previously described (22). Thresholding was used to define the total area and centroid of each microcolony, and 0.01 pixel2 squares were selected to calculate values. Peripheral measurements depict bacteria in contact with host cells; peripheral cells are highlighted outside dotted lines in Fig. 2E, Fig. 3E and F.
ACKNOWLEDGMENTS
We thank the members of the Davis lab for constructive feedback and suggestions during manuscript preparation. We thank Ralph Isberg for invaluable feedback throughout.
We declare no conflicts of interest.
This work was supported by a NIAID K22 Career Transition Award (1K22AI123465-01).
The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Formal analysis: J.R.R., K.M.D. Data curation: J.R.R., K.M.D. Investigation: J.R.R., A.L.E., B.L., K.M.D. Writing—original draft: K.M.D. Writing—review & editing: J.R.R., A.L.E., B.L., K.M.D. Conceptualization, funding acquisition, project administration, supervision: K.M.D.
Footnotes
Citation Raneses JR, Ellison AL, Liu B, Davis KM. 2020. Subpopulations of stressed Yersinia pseudotuberculosis preferentially survive doxycycline treatment within host tissues. mBio 11:e00901-20. https://doi.org/10.1128/mBio.00901-20.
Contributor Information
William E. Goldman, University of North Carolina at Chapel Hill.
Scott J. Hultgren, Washington University School of Medicine.
REFERENCES
- 1.Bonacorsi S, Scavizzi M, Guiyoule A, Amouroux J, Carniel E. 1994. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother 38:481–486. doi: 10.1128/aac.38.3.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lucchetti J, Fracasso C, Balducci C, Passoni A, Forloni G, Salmona M, Gobbi M. 2019. Plasma and brain concentrations of doxycycline after single and repeated doses in wild-type and APP23 mice. J Pharmacol Exp Ther 368:32–40. doi: 10.1124/jpet.118.252064. [DOI] [PubMed] [Google Scholar]
- 3.Prideaux B, Via L, Zimmerman M, Eum S, Sarathy J, O’Brien P, Chen C, Kaya F, Weiner D, Chen P, Song T, Lee M, Shim T, Cho J, Kim W, Cho S, Olivier K, Barry C, Dartois V. 2015. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat Med 21:1223–1227. doi: 10.1038/nm.3937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, McKay G, Siehnel R, Schafhauser J, Wang Y, Britigan B, Singh P. 2011. Active starvation responses mediate antibiotic tolerance in biofilms an nutrient-limited bacteria. Science 334:982–986. doi: 10.1126/science.1211037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Pabst B, Pitts B, Lauchnor E, Stewart P. 2016. Gel-entrapped Staphylococcus aureus bacteria as models of biofilm infection exhibit growth in dense aggregates, oxygen limitation, antibiotic tolerance, and heterogeneous gene expression. Antimicrob Agents Chemother 60:6294–6301. doi: 10.1128/AAC.01336-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Stewart P, White B, Boegli L, Hamerly T, Williamson K, Franklin M, Bothner B, James G, Fisher S, Vital-Lopez F, Wallqvist A. 2019. Conceptual model of biofilm antibiotic tolerance that integrates phenomena of diffusion, metabolism, gene expression, and physiology. J Bacteriol 201:e00307-19. doi: 10.1128/JB.00307-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Yan J, Bassler B. 2019. Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms. Cell Host Microbe 26:15–21. doi: 10.1016/j.chom.2019.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Marakalala M, Raju R, Sharma K, Zhang Y, Eugenin E, Prideaux B, Daudelin I, Chen P, Booty M, Kim J, Eum S, Via L, Behar S, Barry C, Mann M, Dartois V, Rubin E. 2016. Inflammatory signaling in human tuberculosis granulomas is spatially organized. Nat Med 22:531–538. doi: 10.1038/nm.4073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Balaban N, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622–1625. doi: 10.1126/science.1099390. [DOI] [PubMed] [Google Scholar]
- 10.Claudi B, Spröte P, Chirkova A, Personnic N, Zankl J, Schürmann N, Schmidt A, Bumann D. 2014. Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell 158:722–733. doi: 10.1016/j.cell.2014.06.045. [DOI] [PubMed] [Google Scholar]
- 11.Lopatkin A, Stokes J, Zheng E, Yang J, Takahashi M, You L, Collins J. 2019. Bacterial metabolic state more accurately predicts antibiotic lethality than growth rate. Nat Microbiol 4:2109–2117. doi: 10.1038/s41564-019-0536-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Zalis E, Nuxoll A, Manuse S, Clair G, Radlinski L, Conlon B, Adkins J, Lewis K. 2019. Stochastic variation in expression of the tricarboxylic acid cycle produces persister cells. mBio 10:e01930-19. doi: 10.1128/mBio.01930-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Manina G, Dhar N, McKinney J. 2015. Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms. Cell Host Microbe 17:32–46. doi: 10.1016/j.chom.2014.11.016. [DOI] [PubMed] [Google Scholar]
- 14.Sukumar N, Tan S, Aldridge B, Russell D. 2014. Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection. PLoS Pathog 10:e1004394. doi: 10.1371/journal.ppat.1004394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Burton N, Schürmann N, Casse O, Steeb A, Claudi B, Zankl J, Schmidt A, Bumann D. 2014. Disparate impact of oxidative host defenses determines the fate of Salmonella during systemic infection of mice. Cell Host Microbe 15:72–83. doi: 10.1016/j.chom.2013.12.006. [DOI] [PubMed] [Google Scholar]
- 16.Shiloh M, Nathan C. 2000. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Curr Opin Microbiol 3:35–42. doi: 10.1016/s1369-5274(99)00048-x. [DOI] [PubMed] [Google Scholar]
- 17.Rowe S, Wagner N, Li L, Beam J, Wilkinson A, Radlinski L, Zhang Q, Miao E, Conlon B. 2020. Reactive oxygen species induce antibiotic tolerance during systemic Staphylococcus aureus infection. Nat Microbiol 5:282–290. doi: 10.1038/s41564-019-0627-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Arnoldini M, Vizcarra I, Peña-Miller R, Stocker N, Diard M, Vogel V, Beardmore R, Hardt W, Ackermann M. 2014. Bistable expression of virulence genes in Salmonella leads to formation of an antibiotic-tolerant subpopulation. PLoS Biol 12:e1001928. doi: 10.1371/journal.pbio.1001928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Jones-Carson J, Zweifel A, Tapscott T, Austin C, Brown J, Jones K, Voskuil M, Vázquez-Torres A. 2014. Nitric oxide from IFNγ-primed macrophages modulates the antimicrobial activity of β-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella. PLoS Negl Trop Dis 8:e3079. doi: 10.1371/journal.pntd.0003079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Peterson L, Philip N, DeLaney A, Wynosky-Dolfi M, Asklof K, Gray F, Choa R, Bjanes E, Buza E, Hu B, Dillon C, Green D, Berger S, Gough P, Bertin J, Brodsky I. 2017. RIPK1-dependent apoptosis bypasses pathogen blockage of innate signaling to promote immune defense. J Exp Med 214:3171–3182. doi: 10.1084/jem.20170347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zhang Y, Khairallah C, Sheridan B, van der Velden A, Bliska J. 2017. CCR2+ inflammatory monocytes are recruited to Yersinia pseudotuberculosis pyogranulomas and dictate adaptive responses at the expense of innate immunity during oral infection. Infect Immun 86:e00782-17. doi: 10.1128/IAI.00782-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Davis K, Mohammadi S, Isberg R. 2015. Community behavior and spatial regulation within a bacterial microcolony in deep tissue sites serves to protect against host attack. Cell Host Microbe 17:21–31. doi: 10.1016/j.chom.2014.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Davis K, Krupp J, Clark S, Isberg R. 2019. Iron-sulfur cluster repair contributes to Yersinia pseudotuberculosis survival within deep tissues. Infect Immun 87:e00533-19. doi: 10.1128/IAI.00533-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Crimmins G, Mohammadi S, Green E, Bergman M, Isberg R, Mecsas J. 2012. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes. PLoS Pathog 8:e1002828. doi: 10.1371/journal.ppat.1002828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mwengee W, Butler T, Mgema S, Mhina G, Almasi Y, Bradley C, Formanik J, Rochester C. 2006. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis 42:614–621. doi: 10.1086/500137. [DOI] [PubMed] [Google Scholar]
- 26.Hoogkamp-Korstanje J. 1987. Antibiotics in Yersinia enterocolitica infections. J Antimicrob Chemother 20:123–131. doi: 10.1093/jac/20.1.123. [DOI] [PubMed] [Google Scholar]
- 27.Lemaitre B, Mazigh D, Scavizzi M. 1991. Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection. Antimicrob Agents Chemother 35:1785–1790. doi: 10.1128/aac.35.9.1785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Hernandez E, Girardet M, Ramisse F, Vidal D, Cavallo J. 2003. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents. J Antimicrob Chemother 52:1029–1031. doi: 10.1093/jac/dkg484. [DOI] [PubMed] [Google Scholar]
- 29.Olsson-Liljequist B, Möllby R. 1990. In vitro activity of norfloxacin and other antibacterial agents against gastro-intestinal pathogens isolated in Sweden. APMIS 98:150–155. doi: 10.1111/j.1699-0463.1990.tb01015.x. [DOI] [PubMed] [Google Scholar]
- 30.Stolk-Engelaar V, Meis J, Mulder J, Loeffen F, Hoogkamp-Korstanje J. 1995. In vitro antimicrobial susceptibility of Yersinia enterocolitica isolates from stools of patients in the Netherlands from 1982–1991. J Antimicrob Chemother 36:839–843. doi: 10.1093/jac/36.5.839. [DOI] [PubMed] [Google Scholar]
- 31.Russell P, Eley S, Bell D, Manchee R, Titball R. 1996. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice. J Antimicrob Chemother 37:769–774. doi: 10.1093/jac/37.4.769. [DOI] [PubMed] [Google Scholar]
- 32.Russell P, Eley S, Green M, Stagg A, Taylor R, Nelson M, Beedham R, Bell D, Rogers D, Whittington D, Titball R. 1998. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother 41:301–305. doi: 10.1093/jac/41.2.301. [DOI] [PubMed] [Google Scholar]
- 33.Andersen J, Sternberg C, Poulsen L, Bjorn S, Givskov M, Molin S. 1998. New unstable variants of green fluorescent protein for studies of transient gene expression in bacteria. Appl Environ Microbiol 64:2240–2246. doi: 10.1128/AEM.64.6.2240-2246.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Keiler K, Waller P, Sauer R. 1996. Role of a peptide tagging system in degradation of proteins synthesized from damaged messenger RNA. Science 271:990–993. doi: 10.1126/science.271.5251.990. [DOI] [PubMed] [Google Scholar]
- 35.Rasmussen B, Noller H, Daubresse G, Oliva B, Misulovin Z, Rothstein D, Ellestad G, Gluzman Y, Tally F, Chopra I. 1991. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother 35:2306–2311. doi: 10.1128/aac.35.11.2306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Degenkolb J, Takahashi M, Ellestad G, Hillen W. 1991. Structural requirements of tetracycline-Tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the Tet repressor. Antimicrob Agents Chemother 35:1591–1595. doi: 10.1128/aac.35.8.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Green E, Clark S, Crimmins G, Mack M, Kumamoto C, Mecsas J. 2016. Fis is essential for Yersinia pseudotuberculosis virulence and protects against reactive oxygen species produced by phagocytic cells during infection. PLoS Pathog 12:e1005898. doi: 10.1371/journal.ppat.1005898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.O’Connor TJ, Boyd D, Dorer MS, Isberg RR. 2012. Aggravating genetic interactions allow a solution to redundancy in a bacterial pathogen. Science 338:1440–1444. doi: 10.1126/science.1229556. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.